Huntington Beach, CA4 Active Studies

Ankylosing Spondylitis Clinical Trials in Huntington Beach, CA

Find 4 actively recruiting ankylosing spondylitis clinical trials in Huntington Beach, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,261
Enrolling

Recruiting Ankylosing Spondylitis Studies in Huntington Beach

About Ankylosing Spondylitis Clinical Trials in Huntington Beach

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Huntington Beach, CA. These studies are seeking a combined 1,261 participants. Research is being sponsored by AstraZeneca, Merck Sharp & Dohme LLC, Regeneron Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Huntington Beach — FAQ

Are there ankylosing spondylitis clinical trials in Huntington Beach?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Huntington Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntington Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Beach research site will contact you about next steps.

Are clinical trials in Huntington Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Beach studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Huntington Beach are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 22, 2026 from ClinicalTrials.gov